Search

everythinglearnresearchcommunity

for

Search:↓

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Adding TERT and BMI1 to certain skin cells can improve their ability to create hair follicles in mice.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Deleting the CD271 gene in mouse skin cells leads to disorganized skin and increased hair growth, suggesting CD271 is important for skin health.

Beta-HPV and MCPyV are linked to certain skin cancers, with ongoing research and vaccine development.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Lack of functional CYLD in mice leads to early aging and cancer.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Hedgehog signaling is crucial for hair development, cadherins affect cell adhesion, neutrophils play a role in skin lesions, and BP230 autoantibodies impact skin stability.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Sparse hairless patches can develop and stabilize in alopecia areata under certain conditions.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

Two siblings had a rare immune disorder caused by a FOXN1 gene mutation.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

A group has developed therapies that show promise for treating cancer and various other conditions.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.